EMERGENT BIOSOLUTIONS INC (EBS) Stock Analyst Ratings
NYSE:EBS - New York Stock Exchange, Inc. - US29089Q1058 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 74% to EBS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.77. This target is 28.45% above the current price.
EBS was analyzed by 7 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about EBS.
In the last month the buy percentage rose by 27 points. So the trust of analysts is improving.
EBS was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-07 | Benchmark | Maintains | Buy -> Buy |
| 2024-09-13 | Rodman & Renshaw | Reiterate | Buy -> Buy |
| 2024-08-22 | Rodman & Renshaw | Initiate | Buy |
| 2024-08-16 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-09 | Benchmark | Reiterate | Buy -> Buy |
| 2024-07-03 | Benchmark | Reiterate | Buy -> Buy |
| 2024-07-02 | Benchmark | Reiterate | Buy -> Buy |
| 2024-06-24 | Benchmark | Reiterate | Buy -> Buy |
| 2024-06-21 | Benchmark | Reiterate | Buy -> Buy |
| 2024-06-20 | Benchmark | Maintains | Buy -> Buy |
| 2024-04-11 | Benchmark | Reiterate | Buy -> Buy |
| 2024-03-07 | Benchmark | Upgrade | Hold -> Buy |
| 2023-11-20 | JP Morgan | Reiterate | Underweight |
| 2023-08-29 | Benchmark | Downgrade | Buy -> Hold |
| 2023-05-31 | Benchmark | Reiterate | Buy -> Buy |
| 2023-05-19 | Benchmark | Reiterate | Buy -> Buy |
| 2023-04-10 | Benchmark | Upgrade | Hold -> Buy |
| 2023-03-17 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-11-10 | Benchmark | Downgrade | Buy -> Hold |
| 2022-11-09 | Chardan Capital | Maintains | Buy |
| 2022-09-12 | Cowen & Co. | Maintains | Market Perform |
| 2022-05-04 | Wells Fargo | Maintains | Equal-Weight |
| 2022-04-29 | Chardan Capital | Maintains | Buy |
| 2022-03-10 | Wells Fargo | Maintains | Equal-Weight |
| 2021-11-10 | Chardan Capital | Maintains | Buy |
| 2021-11-08 | Benchmark | Downgrade | Buy -> Hold |
| 2021-05-05 | Argus Research | Downgrade | Buy -> Hold |